Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000038739 | SCV000051557 | benign | not specified | 2013-06-24 | criteria provided, single submitter | research | |
Laboratory for Molecular Medicine, |
RCV000038739 | SCV000062417 | benign | not specified | 2009-01-19 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000344271 | SCV000365548 | likely benign | Myofibrillar myopathy 4 | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000382414 | SCV000365549 | likely benign | Dilated Cardiomyopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000295142 | SCV000365550 | likely benign | Myofibrillar Myopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000348704 | SCV000365551 | likely benign | Dilated cardiomyopathy 1C | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Invitae | RCV000344271 | SCV000557547 | benign | Myofibrillar myopathy 4 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000038739 | SCV000708001 | likely benign | not specified | 2017-05-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620161 | SCV000735212 | benign | Cardiovascular phenotype | 2015-11-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Athena Diagnostics | RCV000712210 | SCV000842648 | benign | not provided | 2018-04-09 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV000770137 | SCV000901563 | benign | Cardiomyopathy | 2016-02-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000712210 | SCV001845192 | benign | not provided | 2018-11-21 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 27553890) |
Fulgent Genetics, |
RCV002504899 | SCV002798540 | benign | Dilated cardiomyopathy 1C; Myofibrillar myopathy 4 | 2021-10-20 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000038739 | SCV001922085 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000038739 | SCV001931195 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000038739 | SCV001952650 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000038739 | SCV001967514 | benign | not specified | no assertion criteria provided | clinical testing |